The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using 18F-BMS-986229 PET.
 
Samuel Louis Cytryn
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics; Pfizer
 
Neeta Pandit-Taskar
Honoraria - Actinium Pharmaceuticals
Consulting or Advisory Role - Actinium Pharmaceuticals; Fusion Pharmaceuticals; Illumina; Progenics
Speakers' Bureau - Actinium Pharmaceuticals
Research Funding - Bayer Health (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Fusion Pharmaceuticals (Inst); ImaginAb (Inst); Janssen (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bayer
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Honoraria - Clarion Healthcare; Clinical Care Options; Medpage; Physicans' Education Resource; Practicing Clinician Exchange; Vindico Medical Education
Consulting or Advisory Role - Amgen; Bicara Therapeutics; Daichi Sankyo; Elevation Oncology; Novartis
Research Funding - Epic Sciences; Guardant Health (Inst)
 
Ping Gu
No Relationships to Disclose
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Apexigen; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; I-Mab; Jazz Pharmaceuticals; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Adaptimmune (Inst); Arog (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CARsgen Therapeutics (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Triumvira Immunologics, Inc (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; ImaBiotech; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Joanne F. Chou
Stock and Other Ownership Interests - PAIGE.AI (Inst)
Patents, Royalties, Other Intellectual Property - Company Paige.AI MSK has licensed intellectual property related to digital pathology slides and algorithm development to Paige. MSK also holds equity in Paige. AI. (Inst)
 
Marinela Capanu
No Relationships to Disclose
 
Lara Feder
No Relationships to Disclose
 
Steven Philemond
No Relationships to Disclose
 
Serge K. Lyashchenko
Leadership - Evergreen Theragnostics
Stock and Other Ownership Interests - Evergreen Theragnostics
Consulting or Advisory Role - Clarity Pharmaceuticals; Evergreen Theragnostics; YmAbs Therapeutics Inc
 
Jason Stuart Lewis
Leadership - pHLIP
Stock and Other Ownership Interests - Evergreen Theragnostics; pHLIP; Summit Biomedical Imaging; Telix Pharmaceuticals
Consulting or Advisory Role - Clarity Pharmaceuticals; Invicro; TPG Capital; Varian Medical Systems
Research Funding - Curadel; Lilly; MabVax; Merck
Patents, Royalties, Other Intellectual Property - Elucida Oncology; macrocyclics, Inc; Theragnostics
Travel, Accommodations, Expenses - CSRA
 
Viktoriya Paroder
No Relationships to Disclose
 
Heiko Schöder
No Relationships to Disclose
 
Amitabh Srivastava
No Relationships to Disclose
 
Laura H. Tang
Honoraria - Astellas Scientific and Medical Affairs Inc
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Inspirna
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Master Clinician Alliance; Merck; Michael J. Hennessy Associates; Peerview; Research to Practice
Consulting or Advisory Role - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Geneos; GlaxoSmithKline; Guardant Health; Imedex; Imugene; Jazz Pharmaceuticals; Lilly; Lynx Health; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; Paradigm; Peerview; Pfizer; Phanes Therapeutics; Research to Practice; Rgenix; Seagen; Silverback Therapeutics; Zymeworks
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Rgenix (Inst); Transcenta (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Merck
Other Relationship - Axis Medical Education; Clinical Care Options; Research to Practice